FDA Decision To Revoke Avastin For Breast Cancer Use Remains Topic Of Debate
Physicians, lawmakers and advocates continue to debate FDA's decision last month to revoke approval of Genentech's drug Avastin for breast cancer treatment, USA Today reports...